AAHI Awarded $9.9M to Develop Nasal Spray Influenza Vaccine
The 40-month project may culminate in a prototype bivalent vaccine candidate that is effective against both the H5N1 and H7N9 strains of influenza, according to Access to Advanced Health Institute.
